전체 프로그램

ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved23 programs
CGTLimited DatastaleIntrexon CorporationPhase 1

CD33-CAR-T Cell Infusion (CD33-CAR-T Cell Infusion)

Hematopoietic/Lymphoid Cancer; Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 20Status Discontinued
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

Anti-CD33 CAR T-cells (Anti-CD33 CAR T-cells)

Relapsed and/or Refractory Acute Myeloid Leukemia; High Risk Hematologic Malignancies · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 12Status Active
ADCLimited DatastalePfizerPreclinical

Antibody Drug Conjugate Chemotherapeutic (Antibody Drug Conjugate Chemotherapeutic)

CD33 Positive Acute Myelogenous Leukemia · CD33

#CD33#ADC#Preclinical#antibody-drug-conjugate#CD33PositiveAcuteMyelogenousLeuk+1
Trials 8Status Active
CGTLimited DatastaleHangzhou Qihan Biotech Co., Ltd.Phase 1

CD33 CAR-NK cell (CD33 CAR-NK cell)

AML, Adult; Minimal Residual Disease · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 7Status Active
CGTLimited DatastaleSichuan Kelun-Biotech Biopharma…Phase 1

anti-CD33 CAR NK cells (anti-CD33 CAR NK cells)

Leukemia, Myeloid, Acute · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 4Status Active
CGTLimited DatastaleBeijing BiotechPhase 2

Autologous CD33/CD123 dual-target CAR-T module (Autologous CD33/CD123 dual-target CAR-T module)

Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia; Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL · CD33

#CD33#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

Autologous CD33/CLL1 dual-target CAR-T module (Autologous CD33/CLL1 dual-target CAR-T module)

Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia; Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL · CD33

#CD33#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

CD123-CD33 cCAR T cells (CD123-CD33 cCAR T cells)

Hematologic Malignancy; Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleEssen BiotechPhase 2

CD123/CD33 CART (CD123/CD33 CART)

AML; Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleZhejiang UniversityPhase 1

CD33 CAR T-cells (CD33 CAR T-cells)

Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleZhejiang UniversityPhase 1

CD33 CAR-T (CD33 CAR-T)

AML · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleHangzhou Qihan Biotech Co., Ltd.Phase 1

CD33/CLL1 dual CAR-NK cell (CD33/CLL1 dual CAR-NK cell)

AML, Adult; Minimal Residual Disease · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Active
CGTLimited DatastaleCenter for International Blood …Phase 2

CD33CART allogeneic (CD33CART allogeneic)

Acute Myelogenous Leukemia · CD33

#CD33#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleCenter for International Blood …Phase 2

CD33CART autologous (CD33CART autologous)

Acute Myelogenous Leukemia · CD33

#CD33#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

CD33KO-HSPC; CART33 (CD33KO-HSPC; CART33)

Leukemia, Myeloid, Acute · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells (CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells)

Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 1

CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleGuangzhou Bio-gene Technology C…Preclinical

CLL1+CD33 CAR-T (CLL1+CD33 CAR-T)

Acute Myeloid Leukemia · CD33

#CD33#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

CLL1-CD33 cCAR T cells (CLL1-CD33 cCAR T cells)

Hematologic Malignancy; Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleGerman Cancer Research CenterPhase 1

Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion (Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion)

Relapsed/Refractory Acute Myeloid Leukemia (AML) · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting

1 / 2 pages

← PreviousNext →